Rapid, accurate, and easy to perform tests
Saladax’s MyCare Psychiatry product line consists of 5 in vitro diagnostic tests which measure drug levels of the 6 most commonly prescribed antipsychotic drugs. These tests are essential diagnostic tools used by Healthcare Professionals (HCPs) to monitor patient’s blood levels of these prescribed drugs.
MyCare Psychiatry provides rapid insights to aid in patient management when it matters most.1 In light of the serious consequences of unsuccessful treatment, the value of having rapid access to information that may be used to reorient the treatment cannot be overstated. Timely knowledge of antipsychotic serum levels of patients with complicated courses of treatment would allow prescribers to make highly consequential decisions based on data rather than guesswork.
1Horvitz-Lennon, Marcela, Zachary Predmore, and Soeren Mattke, Personalizing Antipsychotic Treatment of Schizophrenia: Monitoring Plasma Levels for Improved Treatment Decisions. Santa Monica, CA: RAND Corporation, 2017. https://www.rand.org/pubs/perspectives/PE174.html.
Every person’s body handles antipsychotic medications differently. MyCare Psychiatry tests provide personalized drug concentrations that help HCPs make reliable treatment decisions for each patient. MyCare offers data-driven clinical decision support to supplement patient self-report and enhance shared decision-making between you and your patient.
of HCPs do not know if their patients are dosed at a correct medication level1
of patients do not tolerate the drug they are taking2
of patients do not respond favorably to the drug3
of polled HCPs agree quantitative insight will improve patient management3
1 Marcus SC, Zummo J, Pettit AR, Stoddard J, Doshi JA. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge. J Manag Care Spec Pharm. 2015;21(9):754-768.
2 Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia. N. Engl. J. Med. 2005;353(12):1209-1223.
3 Janssen Diagnostics, Rand Health, et al. Potential Cost Savings of Having Access to Antipsychotic Plasma Levels at the Point of Care for Patients with Schizophrenia
1 Janssen Diagnostics, Rand Health, et al. Potential Cost Savings of Having Access to Antipsychotic Plasma Levels at the Point of Care for Patients with Schizophrenia
Caregivers have a positive reaction to MyCare and believe the test should be an essential part of loved ones’ treatment. Caregivers almost immediately recognize the benefits that MyCare can provide them.
© 2023 MyCare Tests - USA. All Rights Reserved, Saladax Biomedical Inc.
